CCS
AZN icon

Crosspoint Capital Strategies’s AstraZeneca AZN Stock Holding History

Crosspoint Capital Strategies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-43
Closed -$6K – 168
2015
Q4 		$6K Sell
43
-172
-80% -$11.3K ﹤0.01% 770
2015
Q3 		$14K Hold
215
– – 0.02% 376
2015
Q2 		$14K Hold
215
– – ﹤0.01% 456
2015
Q1 		$15K Buy
215
+149
+226% +$10.4K 0.01% 364
2014
Q4 		$5K Hold
66
– – ﹤0.01% 582
2014
Q3 		$5K Hold
66
– – ﹤0.01% 417
2014
Q2 		$5K Hold
66
– – ﹤0.01% 439
2014
Q1 		$4K Hold
66
– – ﹤0.01% 594
2013
Q4 		$4K Buy
+66
New +$3.58K ﹤0.01% 505

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return